Egetis Therapeutics AB Sustainability Reports
Egetis Therapeutics AB is a pharmaceutical drug development company focusing on late-stage development and commercialization of orphan drugs for serious rare diseases.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300RZCKGWRUBPMY22
FIGI: BBG001V0L0J8
4 reports from 2021 to 2025
